Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
Osimertinib in T790M+ NSCLC Detected by Liquid Biopsy
NCT03394118Phase 2Completed
- Sponsor
- Asan Medical Center
- Start
- Aug 2017
- Primary completion
- Mar 2021
- Modality
- Small Molecules
- Countries
- 1
01
Overview
A Phase 2 trial of osimertinib in non-small cell lung cancer (NSCLC), sponsored by Asan Medical Center. Started Aug 2017; status: completed.
02
Drugs
03
Conditions
non-small cell lung cancer (NSCLC)
Beyond the preview
Go deeper on NCT03394118.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on NCT03394118.